Bios Partners
PE / VC
2020
$272 M
Redwood City, California, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
BIOS Strategic Partners specializes in distributing innovative medical technologies designed to improve patient outcomes and enhance healthcare practices. We partner with clinics, hospitals, and healthcare providers to deliver cutting-edge devices which includes AI software technology to Post Op Recovery. Our Programs and Products help accelerate recovery, enhance patient care and build Practice Management Programs. We are specialists in Workers Compensation, VA hospitals/clinics and Private sector health systems.
Our goal is to bridge the gap between groundbreaking medical innovations and the healthcare systems that need them most.
Industry
Region of investment
Bios Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Bios Fund II NT, LP
|
Private Equity (PE)
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
HealthTech
|
Seed
Series A
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$5 M
|
October 2018
|
